Phase II trial using romidepsin after gemcitabine, dexamethasone, and cisplatin therapy in elderly transplant-ineligible patients with relapsed/refractory peripheral T-cell lymphoma: Study protocol

Satoshi Yamasaki, Akiko Kada, Hirokazu Nagai, Isao Yoshida, Ilseung Choi, Akiko M. Saito, Hiromi Iwasaki

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Phase II trial using romidepsin after gemcitabine, dexamethasone, and cisplatin therapy in elderly transplant-ineligible patients with relapsed/refractory peripheral T-cell lymphoma: Study protocol'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds